Deep research at the intersection of bioscience, systems thinking, and science policy — where the next paradigm shift comes from, and why it happens when it does.
Long-form analysis of bioscience breakthroughs, systems thinking, and science policy.
In-depth research guides — free to read, built to last.
The researcher, writer, and systems thinker behind this work.
Bioscience breakthroughs, systems thinking, and the policy conditions that make science happen.
Free to read. Built for depth.
A systemic analysis of what makes scientific breakthroughs possible — institutions, funding, talent, and timing.
Deep dive into CAR-T cell therapy for autoimmune disease — the science, the trials, and what comes next.
From base editing to bespoke therapies — how CRISPR is outpacing the regulatory frameworks built to govern it.
The researcher and writer behind Corinthian Technologies Incorporated.
I founded Corinthian Technologies Incorporated to document and analyze bioscience breakthroughs — not just what happened, but why it happened here, now, and not somewhere else.
My work sits at the intersection of life sciences, systems thinking, and science policy. I'm particularly focused on autoimmune disorders, gene therapy, and the institutional structures that either accelerate or obstruct breakthrough science.
Current projects include a deep analysis of CAR-T cell therapy for autoimmune disease (University Hospital Erlangen), documentation of the first personalized CRISPR therapy case (CHOP/UPenn, 2025), and a systemic framework for understanding breakthrough conditions.
CHOP/UPenn case — the first bespoke gene therapy built for a single patient's mutation.
Deep dive into University Hospital Erlangen's landmark trials in lupus and systemic sclerosis.
Launched with a focus on bioscience documentation and systemic analysis.